Pentingnya Terapi Dini Common Cold dengan Obat Kumur Antiseptik Povidone Iodine

Oleh :

dr. Reren Ramanda

Penggunaan obat kumur antiseptik povidone iodine (PVP-I) di awal gejala common cold dapat menurunkan viral load sehingga mempercepat proses penyembuhan. Common cold atau selesma merupakan infeksi saluran pernapasan atas yang disebabkan oleh infeksi virus, terutama Rhinovirus, sehingga tidak memerlukan terapi antibiotik. Penanganan common cold yang tidak cepat dan tepat dapat menyebabkan komplikasi lebih lanjut atau bahkan koinfeksi bakteri.[1-4]

Komplikasi common cold antara lain otitis media, sinusitis, bronkiolitis, pneumonia, dan eksaserbasi asma atau penyakit paru obstruksi. Oleh karena itu, peran dokter pada penatalaksanaan common cold sangat penting untuk mencegah perburukan. Saat ini, penggunaan obat kumur (gargle) antiseptik dapat menjadi pilihan terapi dini bagi pasien common cold, mengingat profil risikonya yang cukup dapat ditoleransi dan sudah digunakan selama beberapa dekade tanpa ditemukan adanya efek samping berat yang permanen.[4]

Imunitas Tubuh dan Common Cold

(Konten ini khusus untuk dokter. Registrasi untuk baca selengkapnya)

Referensi

1. Degeorge,KC; Ring,DJ and Dalrymple,SN. Treatment of the Common Cold. Am Fam Physician. 2019;100(5):281-289. https://www.aafp.org/pubs/afp/issues/2019/0901/p281.html
2. Keshvari, et al. Exploring health seeking behaviors for common cold management. Explor Res Clin Soc Pharm. 2023 Jul 11;11:100301. https://pmc.ncbi.nlm.nih.gov/articles/PMC10392600/
3. Eggers,M et al. In Vitro Bactericidal and Virucidal Efficacy of Povidone-Iodine Gargle/Mouthwash Against Respiratory and Oral Tract Pathogens. Infect Dis Ther. 2018 Apr 9;7(2):249–259. https://pmc.ncbi.nlm.nih.gov/articles/PMC5986684/
4. Eccles, R. Common cold. Front Allergy. 2023 Jun 22;4:1224988. https://pmc.ncbi.nlm.nih.gov/articles/PMC10324571/
5. De Angelis, ML. et al. Repeated Exposure to Subinfectious Doses of SARS-CoV-2 May Promote T Cell Immunity and Protection against Severe COVID-19. Viruses. 2021 May 22;13(6):961. https://pmc.ncbi.nlm.nih.gov/articles/PMC8224680/
6. Leschak, CJ and Eisenberger, NI. Two Distinct Immune Pathways Linking Social Relationships With Health: Inflammatory and Antiviral Processes. Psychosom Med. 2019 Oct;81(8):711–719. https://pmc.ncbi.nlm.nih.gov/articles/PMC7025456/
7. Capoor, MN.et al. Is the “Common Cold” Our Greatest Ally in the Battle Against SARS-CoV-2? Front Cell Infect Microbiol. 2020 Dec 18;10:605334. https://pmc.ncbi.nlm.nih.gov/articles/PMC7775357/
8. Munoz, IS. Et al. Social Distancing, Lockdown and the Wide Use of Mask; A Magic Solution or a Double-Edged Sword for Respiratory Viruses Epidemiology?. Vaccines (Basel). 2021 Jun 3;9(6):595. https://pmc.ncbi.nlm.nih.gov/articles/PMC8228489/
9. Chiu, NC. Et al. Impact of Wearing Masks, Hand Hygiene, and Social Distancing on Influenza, Enterovirus, and All-Cause Pneumonia During the Coronavirus Pandemic: Retrospective National Epidemiological Surveillance Study. J Med Internet Res. 2020 Aug 20;22(8):e21257. https://pmc.ncbi.nlm.nih.gov/articles/PMC7471891/
10. Cohen, R. et al. Pediatric Infectious Disease Group (GPIP) position paper on the immune debt of the COVID-19 pandemic in childhood, how can we fill the immunity gap? Infectious Diseases Now. Volume 51, Issue 5, August 2021, Pages 418-423. https://www.sciencedirect.com/science/article/pii/S2666991921001123?via%3Dihub#bib0265
11. Drugbank. Povidone-iodine. 2024. https://go.drugbank.com/drugs/DB06812
12. Eggers, M. Infectious Disease Management and Control with Povidone Iodine. Infect Dis Ther 8, 581–593 (2019). https://link.springer.com/article/10.1007/s40121-019-00260-x#citeas
13. Sachez, AG. Et al. Povidone-Iodine as a Pre-Procedural Mouthwash to Reduce the Salivary Viral Load of SARS-CoV-2: A Systematic Review of Randomized Controlled Trials. Int J Environ Res Public Health. 2022 Mar 1;19(5):2877. https://pmc.ncbi.nlm.nih.gov/articles/PMC8909935/
14. Australian Commision on Safety and Quality in Health Care. Managing a sore throat associated with COVID-19. 2020. https://www.safetyandquality.gov.au/sites/default/files/2020-05/covid-19_-_position_statement_-_managing_a_sore_throat_associated_with_covid-19_-_29_april_2020.pdf
15. Matsuyama, A. et al. A prospective, randomized, open-label trial of early versus late povidone-iodine gargling in patients with COVID-19. Scientific Reports volume 12, Article number: 20449 (2022). https://www.nature.com/articles/s41598-022-24683-8
16. Guenezan J. et al. Povidone Iodine Mouthwash, Gargle, and Nasal Spray to Reduce Nasopharyngeal Viral Load in Patients With COVID-19. JAMA Otolaryngol Head Neck Surg. 2021 Feb 4;147(4):400–401. https://pmc.ncbi.nlm.nih.gov/articles/PMC7863011/
17. Quek, AML., Ng, MY., et al. Stable thyroid function despite regular use of povidone-iodine throat spray for SARS-CoV-2 prophylaxis. Annals of Medicine. 2022. 54(1), 3298–3304. https://doi.org/10.1080/07853890.2022.2108132